HAYWARD, Calif., April 17, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today confirmed its plan to release the Company's financial results for the first quarter ended March 31, 2012, after market close on Tuesday, May 1, 2012. The Company will also host a conference call and webcast on Tuesday, May 1, 2012, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate developments. The dial-in number for the conference call is 877-941-6010 for domestic participants and 480-629-9770 for international participants.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant™, body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO™. As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Clear + Brilliant is a unique, cost-effective treatment to prevent and improve the early signs of photoaging utilizing Fraxel technology. For body contouring, Liposonix is a non-surgical treatment to reduce waist circumference with advanced high-intensity focused ultrasound (HIFU) technolo
|SOURCE Solta Medical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved